Quintrio
Home

Stock overview

Polyrizon Ltd. Ordinary Shares

PLRZ

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $10.40 – $11.48
Volume 12,924
Market cap $26M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for PLRZ.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for PLRZ.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025

Polyrizon Ltd. (Nasdaq: PLRZ), a pre-clinical-stage biotechnology company, announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the SEC. The company specializes in developing intranasal protective solutions using proprietary hydrogel technology delivered as nasal sprays to create a barrier against viruses and allergens.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Nov 28, 20251-for-6reverse split
May 27, 20251-for-250reverse split